You-Cheng Lin
Impact in
- Drug Discovery top 10%
- Biotechnology top 10%
- Marine Sponges and Natural Products
Papers in
-
- Ubiquitin and proteasome pathways 2
- Glycosylation and Glycoproteins Research 2
-
- Marine Sponges and Natural Products 7
- Co-authors
- Jyh‐Horng Sheu (9 shared papers)Michael Y. Chiang (2 shared papers)Chang‐Feng Dai (2 shared papers)Chi‐Chen Lin (4 shared papers)Jui‐Hsin Su (1 shared paper)Wan‐Yu Liu (1 shared paper)Yi Lu (1 shared paper)Tsong‐Long Hwang (3 shared papers)
- Journals
- Marine Drugs (2 papers)Tetrahedron (2 papers)International Immunopharmacology (1 paper)Frontiers in Pediatrics (1 paper)RSC Advances (1 paper)
- Partner nations
- TaiwanChinaSaudi Arabia
In The Last Decade
You-Cheng Lin
25 papers receiving 246 citations
Peers
Comparison fields: 5 of 70
- Drug Discovery 2
- Biotechnology 73
- Toxicology 13
- Cancer Research 52
- Pharmacology 46
Countries citing papers authored by You-Cheng Lin
This map shows the geographic impact of You-Cheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You-Cheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You-Cheng Lin more than expected).
Fields of papers citing papers by You-Cheng Lin
This network shows the impact of papers produced by You-Cheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You-Cheng Lin. The network helps show where You-Cheng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside You-Cheng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 44 | |
| 2 | 2015 | 27 | |
| 3 | 2015 | 17 | |
| 4 | 2020 | 16 | |
| 5 | 2022 | 15 | |
| 6 | 2015 | 15 | |
| 7 | 2015 | 13 | |
| 8 | 2020 | 12 | |
| 9 | Fucosyltransferase 8 modulates receptor tyrosine kinase activation and temozolomide resistance in glioblastoma cells. | 2021 | 12 |
| 10 | 2021 | 9 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2018 | 7 | |
| 15 | 2019 | 6 | |
| 16 | 2014 | 6 | |
| 17 | 2018 | 5 | |
| 18 | 2018 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2023 | 4 |
About You-Cheng Lin
You-Cheng Lin is a scholar working on Molecular Biology, Biotechnology, Pharmacology, Organic Chemistry and Surgery, having authored 26 papers that have together received 249 indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (7 papers), Microbial Natural Products and Biosynthesis (4 papers), Synthetic Organic Chemistry Methods (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers), Ubiquitin and proteasome pathways (2 papers), Microtubule and mitosis dynamics (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Drug Discovery (2 citations), Biotechnology (73 citations), Toxicology (13 citations), Cancer Research (52 citations) and Pharmacology (46 citations). You-Cheng Lin has collaborated with scholars based in Taiwan, China and Saudi Arabia. Frequent co-authors include Jyh‐Horng Sheu, Michael Y. Chiang, Chang‐Feng Dai, Chi‐Chen Lin, Jui‐Hsin Su, Wan‐Yu Liu, Yi Lu, Tsong‐Long Hwang, Zhi‐Hong Wen and Yao‐Haur Kuo. Their work appears in journals such as Marine Drugs, Tetrahedron, International Immunopharmacology, Frontiers in Pediatrics and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.